Evonik has launched a new biosurfactant produced from renewable feedstocks, said the company.
The rhamnolipids are produced at Evonik’s plant in Slovenska Lupca, Slovakia following a triple-digit million-euro investment in the site, which is scheduled to be completed by the end of 2023. The biosurfactant range is made using feedstocks which are locally sourced and fully biodegradable, meeting demand for low-emission, low-impact cleaning products in the market.
As Evonik holds the IP-protected manufacturing process, this enables them to sell a unique product on the market and is a step towards shifting its Nutrition & Care life sciences business segment towards system solutions. System solutions have high growth prospects and above-average margin potential, and Evonik plans to increase the share of system solutions in its Nutrition and Care segment from 20% to more than 50% by 2030.
As MRC reported before, Evonik is investing a three-digit million-euro sum in the construction of a new production plant for bio-based and fully biodegradable rhamnolipids. The decision to build the plant follows a breakthrough in Evonik's research and development. Rhamnolipids are biosurfactants and serve as active ingredients in shower gels and detergents. Demand for environ-mentally friendly surfactants is growing rapidly worldwide.
We remind that in February, 2020, Dow and Evonik entered into an exclusive technology partnership. Together, they plan to bring a unique method for directly synthesizing propylene glycol (PG) from propylene and hydrogen peroxide to market maturity.
Evonik is one of the world leaders in specialty chemicals. The company is active in more than 100 countries around the world and generated sales of EUR12.2 billion and an operating profit (adjusted EBITDA) of EUR1.91 billion in 2020. Evonik goes far beyond chemistry to create innovative, profitable and sustainable solutions for customers. About 33,000 employees work together for a common purpose: to improve life today and tomorrow.
mrchub.com